相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defibrotide-treated patients with anicteric or icteric veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic cell transplantation: an EBMT study
Mohamad Mohty et al.
BONE MARROW TRANSPLANTATION (2022)
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
Mary Nauffal et al.
BLOOD ADVANCES (2022)
Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluations
Alois Gratwohl
JOURNAL OF MEDICAL ECONOMICS (2021)
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study
Mohamad Mohty et al.
BONE MARROW TRANSPLANTATION (2021)
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation
David Kliman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients
Selim Corbacioglu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? Prospective evaluation of pediatric EBMT criteria for VOD
Zofia Szmit et al.
BONE MARROW TRANSPLANTATION (2020)
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Dietrich Wilhelm Beelen et al.
LANCET HAEMATOLOGY (2020)
Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes
John Coutsouvelis et al.
SUPPORTIVE CARE IN CANCER (2018)
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
Christopher Strouse et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Pre-emptive strikethe case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide
Revathi Rajagopal et al.
PEDIATRIC BLOOD & CANCER (2018)
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation
S. Corbacioglu et al.
BONE MARROW TRANSPLANTATION (2018)
Long-Term Outcome After a Treosulfan-Based Conditioning Regimen for Patients With Acute Myeloid Leukemia: a Report From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler et al.
CANCER (2017)
Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children
J. C. Naples et al.
BONE MARROW TRANSPLANTATION (2016)
Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment
Jean-Hugues Dalle et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
Paul G. Richardson et al.
BLOOD (2016)
Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation
John Coutsouvelis et al.
CANCER TREATMENT REVIEWS (2016)
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Paul G. Richardson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Selim Corbacioglu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Paul G. Richardson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
M. Mohty et al.
BONE MARROW TRANSPLANTATION (2015)
How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation
Enric Carreras
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Veno-Occlusive Disease of the Liver in the Absence of Elevation in Bilirubin in Pediatric Patients after Hematopoietic Stem Cell Transplantation
Kasiani C. Myers et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Defibrotide: Properties and clinical use of an old/new drug
R. Pescador et al.
VASCULAR PHARMACOLOGY (2013)
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
Selim Corbacioglu et al.
LANCET (2012)
Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
Selim Corbacioglu et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last Decade
Enric Carreras et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Defibrotide Prevents the Activation of Macrovascular and Microvascular Endothelia Caused by Soluble Factors Released to Blood by Autologous Hematopoietic Stem Cell Transplantation
Marta Palomo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children
Amrana Qureshi et al.
PEDIATRIC BLOOD & CANCER (2008)
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies
V. T. Ho et al.
BONE MARROW TRANSPLANTATION (2008)
Defibrotide for the treatment of hepatic veno-occlusive disease in children
Sean R. Bulley et al.
PEDIATRIC BLOOD & CANCER (2007)
Treatment of sinusoidal obstruction syndrome with defibrotide:: A single-center experience
G. T. Sucak et al.
TRANSPLANTATION PROCEEDINGS (2007)
Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
Y Chalandon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
分享论文
